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Abstract 
Objectives: Four‑dimensional flow CMR allows for a comprehensive assessment of the blood flow kinetic energy 
of the ventricles of the heart. In comparison to standard two‑dimensional image acquisition, 4D flow CMR is felt to 
offer superior reproducibility, which is important when repeated examinations may be required. The objective was to 
evaluate the inter‑observer and intra‑observer reproducibility of blood flow kinetic energy assessment using 4D flow 
of the left ventricle in 20 healthy volunteers across two centres in the United Kingdom and the Netherlands.
Data description: This dataset contains 4D flow CMR blood flow kinetic energy data for 20 healthy volunteers with 
no known cardiovascular disease. Presented is kinetic energy data for the entire cardiac cycle (global), the systolic and 
diastolic components, in addition to blood flow kinetic energy for both early and late diastolic filling. This data is avail‑
able for reuse and would be valuable in supporting other research, such as allowing for larger sample sizes with more 
statistical power for further analysis of these variables.
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Objective
Quantitative cardiovascular magnetic resonance (CMR) 
imaging can provide a wealth of information to distin-
guish health from disease [1]. Four-dimensional flow (4D 
flow) CMR allows for a comprehensive assessment of the 
blood flow kinetic energy (KE) of the left ventricle (LV) 
[2]. Assessment of LV KE by 4D flow CMR is thought 
to offer superior reproducibility compared to standard 
two-dimensional phase contrast acquisition [3]. In our 
publication, for which this dataset corresponds to [4], 
we set out to answer questions we felt to be fundamen-
tal in evaluating the diagnostic utility of 4D flow CMR. 
First, we determined the normal ranges of LV KE values 
across the spectrum of age, which is an important step 
in differentiating between healthy and diseased states. 
Second, given the established association between stand-
ard 2D parameters of diastolic function and the myocar-
dial stiffening accompanying the ageing process [5], we 
investigated the association of LV blood flow KE using 
4D flow CMR with 2D mitral inflow and myocardial tis-
sue velocities by CMR. Third, we assessed inter-observer 
and intra-observer reproducibility of 4D flow CMR LV 
KE assessments. Reproducibility is a prerequisite for any 
investigatory technique where repeated examinations 
may be required.
Reproducibility in cardiac MRI research is a pervasive 
issue across the field, which impacts the translational 
pathway [6]. Given the relative infancy of research within 
4D flow CMR and the accepted potential for this imaging 
technique to propel our understanding of cardiovascu-
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repeatability of the various aspects of the techniques, 
ideally across multiple centres. We hope the publication 
of our data will offer further opportunities to generate 
research which contributes to our growing understand-
ing of the diagnostic utility of 4D flow CMR techniques. 
Our data will be of particular use to research groups 
incorporating reproducibility analysis within validation 
studies, and is available for reuse and assimilation within 
quantitative syntheses.
Data description
The dataset includes the LV blood flow KE parameters of 
twenty healthy adult volunteers void of any known cardi-
ovascular disease, collected from two sites in the United 
Kingdom (Leeds) and the Netherlands (Leiden). CMR 
was performed on a dedicated cardiovascular 1.5 Tesla 
Phillips Ingenia system equipped with a 28-channel coil 
and Phillips dStream digital broadband MR architecture 
technology. The data was acquired following analysis of 
CMR images using dedicated 4D flow research soft-
ware (Mass; Version 2017EXP, Leiden University Medi-
cal Center, Leiden, The Netherlands). After acquiring 
images, advanced 4D flow CMR techniques were applied 
to determine the kinetic energy (KE) for each phase of 
the cardiac cycle, following which all KE parameters were 
normalized to the LV end-diastolic volume, and reported 
in standard units (μJ/ml).
The dataset is composed of two parts. First, inter-
observer reproducibility. This refers to two separate 
operators analysing the twenty cases independent of 
each other. Second, intra-observer reproducibility. This 
refers to the same operator analysing the same ten cases 
on two separate occasions, with a three-month interval 
between. The data presented is the endpoint of a range 
of software-delivered processing of the images, which 
is beyond the scope of this report. Further detail on the 
4D LV KE mapping can be found within our primary 
publication on this topic [4]. The reproducibility aspect 
presented within the dataset is the result of assessor con-
touring of the short-axis LV cine volumetric stacks prior 
to automation and manual readjustment. The number 
of cases for both inter- and intra-observer reproduc-
ibility exceeds the minimum number required as per 
power calculations based upon previous KE studies. This 
dataset should serve as a valuable benchmark for other 
research groups in establishing the required sample sizes 
to ensure adequate statistical power within CMR trials, 
based on the reproducibility outcomes identified from 
this cohort. This dataset, when analysed using the appro-
priate correlation statistical tests, demonstrated excellent 
concordance in global KE parameters for both inter and 
intra-observer reproducibility analyses.
For each case within the two reproducibility analy-
ses, we include data for: global LV KE (an average KE of 
the LV flow for the complete cardiac cycle), systolic KE 
(the average KE of the LV flow during systole), diastolic 
KE (the average KE of the LV flow during diastole), peak 
E-wave KE (the peak KE of the LV flow during early dias-
tolic filling), and peak A-wave KE (the peak KE of the LV 
flow during late diastolic filling).
Limitations
The temporal resolution of 4D flow is 40 ms (ms), which 
may impact the precision of KE assessments. This is an 
issue characteristic of 4D flow analyses, rather than a lim-
itation unique to our dataset. 4D flow was acquired dur-
ing free-breathing, for which issues relating to heart rate 
may have impacted on the time-varying flow characteris-
tics, which could not be corrected for. There are no other 
immediate limitations of this dataset.
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